Logotype for Sumitomo Chemical India Limited

Sumitomo Chemical India (SUMICHEM) Q1 26/27 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sumitomo Chemical India Limited

Q1 26/27 earnings summary

27 Jul, 2026

Executive summary

  • Revenue grew 1% year-over-year to Rs. 1,063 crore (₹10,633.46 million) in Q1FY27, despite adverse agro-climatic conditions and subdued domestic demand.

  • Gross profit increased 4% YoY, with margin expansion to 39.2% due to pricing actions and favorable product mix.

  • EBITDA rose 6% YoY to Rs. 233 crore, with margin up 120 bps to 21.9%.

  • Net profit surged 20% YoY to Rs. 215 crore (₹2,148.30 million), aided by a Rs. 27 crore (₹268.96 million) insurance claim from a prior plant fire.

  • Export revenues grew 26% YoY, now comprising 16% of total revenue, offsetting weak domestic sales.

Financial highlights

  • Q1FY27 revenue: Rs. 1,063.3 crore (₹10,633.46 million, +1% YoY); gross profit: Rs. 416.7 crore (+4% YoY); gross margin: 39.2% (+111 bps YoY).

  • EBITDA: Rs. 233.3 crore (+6% YoY); EBITDA margin: 21.9% (+120 bps YoY).

  • Net profit: Rs. 215 crore (₹2,148.30 million, +20% YoY); net margin: 20.2% (+332 bps YoY).

  • Cash & equivalents at June 2026: Rs. 2,549 crore; net working capital days increased to 56 (from 43 YoY) due to seasonal inventory build-up.

  • Basic and diluted EPS for Q1 FY27 stood at ₹4.30, compared to ₹3.57 in Q1 FY26.

Outlook and guidance

  • Focus remains on sustainable growth via differentiated products, disciplined execution, and enhanced channel engagement.

  • Launches of Topgrain and Helibax planned for Q2FY27 to support future growth.

  • Performance is seasonal and depends on monsoon and climatic conditions.

  • Regulatory uncertainty remains regarding glyphosate usage, pending court resolution.

  • Improved monsoon progress and sowing activity expected to aid recovery in domestic demand.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more